Sarah Sammons, MD, associate director of the metastatic breast cancer program at Dana-Farber Cancer Institute, and Virginia Kaklamani, MD, leader of the breast medical oncology program at Mays Cancer Center at UT Health San Antonio, reflect on the highest impact science of 2023 in breast cancer research.
▷ Estimated Read Time:
1–2 minutes
SABCS Snippets: Reflections on breast cancer advancements for 2023
Connect with thousands of basic and translational scientists, multidisciplinary clinicians, regulatory and pharmaceutical partners, survivors, and patient advocates at the 49th annual San Antonio Breast Cancer Symposium. Complete your registration by Friday, September 25, to take advantage of discounted early registration rates.
Share:
Recent Posts
Recent Posts
-
December 15, 2025
-
December 15, 2025
-
December 15, 2025
-
December 15, 2025
